ArticleFrontiers in immunology2025

IL-12 and GM-CSF engineered dendritic cells enhance the enrichment and selection of tumor-reactive T cells for cancer immunotherapy.

Zhen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.